Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Study shows effects of psychotropic drug treatment on brain morphology

Study shows effects of psychotropic drug treatment on brain morphology

Antidepressives reduce risk of suicides in schizophrenic patients

Antidepressives reduce risk of suicides in schizophrenic patients

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Report: Nursing homes and anti-psychotic drugs

Report: Nursing homes and anti-psychotic drugs

Johnson & Johnson fined $1.2B for hiding anti-psychotic drug dangers, deceptive marketing

Johnson & Johnson fined $1.2B for hiding anti-psychotic drug dangers, deceptive marketing

First Edition: April 12, 2012

First Edition: April 12, 2012

Olanzapine improves survival in mouse model of anorexia nervosa

Olanzapine improves survival in mouse model of anorexia nervosa

Prenatal antipsychotic drug exposure may reduce scores on infant neuromotor screening

Prenatal antipsychotic drug exposure may reduce scores on infant neuromotor screening

Study evaluates efficacy of CBT in obsessive-compulsive disorder

Study evaluates efficacy of CBT in obsessive-compulsive disorder

Mylan receives FDA approval for generic Seroquel ANDA

Mylan receives FDA approval for generic Seroquel ANDA

Researchers identify DNA methylation in patients with schizophrenia

Researchers identify DNA methylation in patients with schizophrenia

Feds reject J & J's $1 billion drug settlement

Feds reject J & J's $1 billion drug settlement

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

Loss of glutamate receptor linked to negative effects of chronic stress

Loss of glutamate receptor linked to negative effects of chronic stress

BioLineRx receives European patent for BL-1020 to treat schizophrenia

BioLineRx receives European patent for BL-1020 to treat schizophrenia

Gedeon Richter and Forest Labs' cariprazine Phase III trials on schizophrenia meet primary endpoint

Gedeon Richter and Forest Labs' cariprazine Phase III trials on schizophrenia meet primary endpoint

AHCA, NCAL announce multi-year Quality Initiative

AHCA, NCAL announce multi-year Quality Initiative

Weight gain or loss may also depend on medicines taken

Weight gain or loss may also depend on medicines taken

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.